loader
Please Wait
Applying Filters...

Quotient Sciences Translational Pharmaceuticals Quotient Sciences Translational Pharmaceuticals

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Looking for Poly DL Lactide co Glycolide ? Find Controlled & Modified Release & other pharma excipients for Tablet dosage forms on PharmaCompass.

    Nippon provides high-performance, high-value-added cosmetic, pharmaceutical, and industrial raw materials.
    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.
    Previous
    Next
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Seqens (1)

    02 Nomisma Healthcare (1)

    filter

    01 France (1)

    02 India (1)

    Close
    4
    refresh Reset Filter
    refreshReset Filter
    Learn More #LearnMore
    price-trend Ask Us

    Seqens

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EXPANSORB® PLGA/PLA

    PDF Supplier PDF
    URL Supplier Web Content
    LM Application #LearnMore

    Applications:

    Poly(D,L-lactide-co-glycolide) acid (PLGA) multifunctional polymers, used to increase substance bioavailability, improving substance stability during formulation & in controlled or localized release in various dosage forms.

    Ingredient(s): Poly DL Lactide co Glycolide

    Dosage Form: Tablet

    Category: Controlled & Modified Release

    Route of Administration (Grade): Oral, Parenteral
    Pharmacopoeia Reference: NA

    Technical Specifications: Classic, ultrapure low-monomer & powder grades.

    Expansorb® PLGA/PLA

    CPhI Worldwide 2023

    Booth # 7C30

    envelop Contact Supplier

    Nomisma Healthcare

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag India
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      PLGA

      PDF Supplier PDF
      URL Supplier Web Content
      LM Application #LearnMore

      Applications:

      PLGA (Poly (Lactic-Co-Glycolic Acid)) is a unique base polymer for controlled release of drugs & medical implant materials. It is biodegradable & biocompatible and since both monomers occur naturally it has minimal toxicity.

      Ingredient(s): Poly DL Lactide co Glycolide

      Dosage Form: Tablet

      Category: Controlled & Modified Release

      Route of Administration (Grade): Oral, Parenteral
      Pharmacopoeia Reference: NA

      Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10 and custom, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

      CPHI India 2023

      Attending

      envelop Contact Supplier

      Post Enquiry
      POST ENQUIRY